BCL2 and Alzheimer disease: In any case, strategies that elevate BCL2 protein levels may provide neuroprotective effects through the targeting of ryanodine receptors by BCL2.470 Adeno-associated viral vectors expressing BCL2 proteins stereotactically injected in the brain of AD mice exerted synaptoprotective and amyloid-protective effects.